


Henlius USA
Biotechnology Research • Milpitas, California, United States • 21-50 Employees
Company overview
| Headquarters | 430 N McCarthy Blvd, Milpitas, California 95035, US |
| Website | |
| NAICS | 541714 |
| Keywords | Science, Biotech, In Vitro, Bioinformatics, In Vivo, Protein Sciences |
| Founded | 2010 |
| Employees | 21-50 |
Key Contacts at Henlius USA
Van Chau
Executive Director Of Global Bd&L, Clinical Operations & Clinical Development
Jen-Kuan Chang
Associate Director, Innovation Center
Zichao Zhang
Senior Legal/Ip Director
Yanling Wang
Sr. Director Of Synthetic Biology
Henlius USA Email Formats
Henlius USA uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@henlius.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@henlius.com | 100% |
About Henlius USA
Henlius USA Inc., located in Milpitas, CA, focuses on developing and delivering high-quality, innovative, and affordable medicine to patients worldwide to treat a range of chronic and life-threatening diseases with a focus in oncology and autoimmune diseases. Henlius USA Inc., is affiliated with Shanghai Henlius Biotech, a global biopharmaceutical company established in 2010. Henlius’ diverse pipeline of over 20 innovative monoclonal antibodies (mAb) includes 汉利康® (HLX01, rituximab injection, the first commercially launched biosimilar in China), 汉曲优® (HLX02, trastuzumab injection, Zercepac® in the EU, first Chinese mAb biosimilar approved in both EU and China), 2 products under NDA review, and over 20 clinical studies for 10 products and 8 combination therapies worldwide. Our goal at Henlius USA Inc., is to accelerate the discovery and development of innovative biologics (such as monoclonal and bispecific antibody) through technical and operational excellence and to build a leading immuno-oncology franchise with a diverse and distinguished product portfolio. We aim to be a globally trusted biotech company dedicated to bringing affordable, innovative treatment to patients with unmet medical needs worldwide. Henlius: http://www.henlius.com
Henlius USA revenue & valuation
| Annual revenue | $3,678,865 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $11,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Henlius USA has 24 employees across 9 departments.
Departments
Number of employees
Funding Data
Henlius USA has never raised funding before.
Frequently asked questions
4.8
40,000 users



